Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1—Biosimilar and Originator Infliximab in the Hospital Setting

BACKGROUND: Decentralisation of healthcare budgets and issuance of local guidelines means that the use of biosimilars can vary by region within a particular country, for example between the 21 counties of Sweden. OBJECTIVES: This study aimed to analyse the county-level market dynamics of biosimilar...

Descripción completa

Detalles Bibliográficos
Autores principales: Moorkens, Evelien, Simoens, Steven, Troein, Per, Declerck, Paul, Vulto, Arnold G., Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533410/
https://www.ncbi.nlm.nih.gov/pubmed/30945207
http://dx.doi.org/10.1007/s40259-019-00345-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533410/
https://www.ncbi.nlm.nih.gov/pubmed/30945207
http://dx.doi.org/10.1007/s40259-019-00345-6

Ejemplares similares